SCHEMBL20580879

SCHEMBL20580879

Cn1cc(NC(=O)O)cc1C(=O)Nc1ccc2oc(C(=O)N3CCOCC3)cc2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 6/20 0.51
▸ HRH4 Q9H3N8 2/20 0.45
▸ HRAS P01112 4/20 0.44
▸ ESR1 P03372 4/20 0.44
▸ ESR2 Q92731 4/20 0.44
▸ NPC1 O15118 5/20 0.43
▸ TP53 P04637 4/20 0.43
▸ MAPK1 P28482 3/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ LMNA P02545 3/20 0.42
▸ MAPT P10636 3/20 0.42
▸ ALDH1A1 P00352 3/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ KDM4E B2RXH2 2/20 0.42
▸ HSD17B10 Q99714 2/20 0.42
▸ POLB P06746 2/20 0.42
▸ SYK P43405 1/20 0.42
▸ GAA P10253 1/20 0.41
▸ USP2 O75604 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20580855 0.91 RAB9A (0.50) RAB9AHRH4HRASESR1ESR2
SCHEMBL20581440 0.90 HRH4 (0.44) RAB9AHRH4HRASESR1ESR2
SCHEMBL18976206 0.88 RAB9A (0.46) RAB9AHRH4HRASESR1ESR2
SCHEMBL20581159 0.82 TP53 (0.50) RAB9ATP53LMNAKMT2ATHRB
SCHEMBL20581209 0.81 HRAS (0.49) RAB9AHRASESR1ESR2NPC1
SCHEMBL20580633 0.80 GAA (0.49) HRH4TP53KMT2ASYKGAA
SCHEMBL20581348 0.80 HRAS (0.49) RAB9AHRASESR1ESR2NPC1
SCHEMBL18976462 0.79 NPC1 (0.45) RAB9AHRH4HRASESR1ESR2
SCHEMBL20581386 0.79 TP53 (0.43) TP53KMT2APOLBTHRB
SCHEMBL18976466 0.78 HRAS (0.41) RAB9AHRH4HRASESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10640507-B2 PBD antibacterial agents KING'S COLLEGE LONDON (GB) 2020-05-05 — — US disclosed
US-20180354958-A1 PBD ANTIBACTERIAL AGENTS Secretary of State for Health and Social Care (GB) 2018-12-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10640507-B2 PBD antibacterial agents OPRD1, XDH, SBDS RAB9A 3045/4885HRH4 13/4885HRAS 3085/4885
US-20180354958-A1 PBD ANTIBACTERIAL AGENTS OPRD1, XDH, SBDS RAB9A 3045/4885HRH4 13/4885HRAS 3085/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback